Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells

Adoptive cell therapy is a rapidly advancing approach to cancer immunotherapy that seeks to facilitate antitumor responses by introducing potent effector cells into the tumor microenvironment. Expanded autologous T cells, particularly T cells with engineered T cell receptors (TCR) and chimeric antig...

Descripción completa

Detalles Bibliográficos
Autores principales: Maddineni, Sainiteesh, Silberstein, John L, Sunwoo, John B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115029/
https://www.ncbi.nlm.nih.gov/pubmed/35580928
http://dx.doi.org/10.1136/jitc-2022-004693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115029/
https://www.ncbi.nlm.nih.gov/pubmed/35580928
http://dx.doi.org/10.1136/jitc-2022-004693

Ejemplares similares